Eric J. Hyllengren - 13 Jul 2026 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Reporting relationship: Chief Financial Officer
Issuer ticker: TNYA
Reported as of: 13 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jul 2026, 21:00:51 UTC
Prior SEC filing: 02 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact

Key filing fact

Eric J. Hyllengren filed Form 4 for Tenaya Therapeutics, Inc. (TNYA) on 14 Jul 2026.

Key facts

This page summarizes Eric J. Hyllengren's Form 4 filing for Tenaya Therapeutics, Inc. (TNYA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Jul 2026, 21:00.

Change

Previous filing in this sequence was filed on 02 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001966926 Primary reporting owner

Hyllengren Eric J

Relationship: Chief Financial Officer
Address: C/0 TENAYA THERALEUTICS, INC., 171 OYSTER POINT BLVD., 5TH FLOOR, SOUTH SAN FRANCISCO
Signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Signature date: 14 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TNYA transaction Derivative

Stock Option (Right to buy)

Award

Transaction value
Shares: +1,650,000
Change %
Price: $0.000000^*
Shares after: 1,650,000
Date: 13 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,650,000
Exercise price: $0.8365
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Option granted pursuant to the Tenaya Therapeutics, Inc. 2024 Inducement Equity Incentive Plan. Option will vest as to 1/4th of the total number of shares subject to the option on the one-year anniversary of the Transaction Date and 1/48th of the total number of shares subject to the option on each monthly anniversary thereafter until fully vested.